Senate Bill S8847

2021-2022 Legislative Session

Relates to establishing an office of antibiotic resistance control and to establishing the antibiotics education fund

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Health Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2021-S8847 (ACTIVE) - Details

See Assembly Version of this Bill:
A10097
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add Art 2 Title 9 §§269-a - 269-n, Pub Health L; add §97-aaaa, St Fin L; amd §218-b, Lab L
Versions Introduced in 2023-2024 Legislative Session:
S4021, A1675

2021-S8847 (ACTIVE) - Summary

Relates to establishing an office of antibiotic-resistance control; establishes the antibiotics education fund; includes methicillin-resistant staphylococcus aureus (MRSA) and other antibiotic-resistant infections in the definition of airborne infectious disease.

2021-S8847 (ACTIVE) - Sponsor Memo

2021-S8847 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8847
 
                             I N  S E N A T E
 
                              April 22, 2022
                                ___________
 
 Introduced  by  Sens.  KAVANAGH,  GOUNARDES,  JACKSON  -- read twice and
   ordered printed, and when printed to be committed to the Committee  on
   Health
 
 AN  ACT  to  amend the public health law, in relation to establishing an
   office of antibiotic-resistance control; to amend  the  state  finance
   law,  in  relation to establishing the antibiotics education fund; and
   to amend the labor law, in relation to including methicillin-resistant
   staphylococcus aureus (MRSA) and other antibiotic-resistant infections
   in the definition of airborne infectious disease
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Legislative findings. Antibiotics are rightfully considered
 one  of the medical miracles of the last century because of their power-
 ful ability to fight illness and disease caused  by  bacteria.  But  the
 effectiveness  of  medically  important antibiotics is now at great risk
 due to their misuse  and  overuse  in  medicine  and  agriculture.  Many
 strains  of  bacteria  have  evolved  resistance to antibiotics, meaning
 instead of being killed  by  the  drugs,  they  survive,  multiply,  and
 spread.  In  fact, the more antibiotics are used, the faster antibiotic-
 resistant bacteria (aka "superbugs")  emerge,  increasing  the  risk  of
 contracting an antibiotic-resistant infection. If effective policy meas-
 ures  are not soon adopted, some experts predict that by 2050, antibiot-
 ic-resistant infections will be responsible for more annual deaths  than
 cancer.
   In  recognition of the serious public health threat posed by antibiot-
 ic-resistant infections, the United Nations  General  Assembly  in  2016
 committed  to taking action. The World Health Organization (WHO) consid-
 ers it to be one of the biggest threats to global health, food security,
 and international development  today.  The  United  States  Centers  for
 Disease  Control  and  Prevention  (CDC)  has  stated that fighting this
 threat is a public health priority and estimates that each year, antibi-
 otic-resistant  bacteria  are  responsible  for  at  least  2.8  million
 infections  in  the  United  States  and at least 35,000 deaths. A study
 commissioned by the United Kingdom government predicts that if action is
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.